Suzanne R. Kesten

951 citations

16 papers · 771 indexed · h-index 11

Toxicology top 5%
Organic Chemistry top 5%
- Synthesis and pharmacology of benzodiazepine derivatives 2
- Synthesis of heterocyclic compounds 2
Pharmacology top 5%
- Cannabis and Cannabinoid Research 2
Cellular and Molecular Neuroscience top 10%
- Neuroscience and Neuropharmacology Research 5
- Neurotransmitter Receptor Influence on Behavior 2
Molecular Biology
- Receptor Mechanisms and Signaling 5
- Pharmacological Receptor Mechanisms and Effects 4
- Ion channel regulation and function 2

Co-authors: Lawrence D. Wise Thomas G. Heffner Thomas A. Pugsley Jonathan L. Wright Stephen J. Johnson Kim Zoski Thomas R. Belliotti David J. Wustrow
Cited by: Toxicology Organic Chemistry Pharmacology
Journals: Journal of Medicinal Chemistry (6 papers)The Journal of Organic Chemistry (1 paper)Tetrahedron Letters (1 paper)
Partner nations: United States

In The Last Decade

Suzanne R. Kesten

16 papers receiving 742 citations

Peers

Countries citing papers authored by Suzanne R. Kesten

Since Specialization

Citations

This map shows the geographic impact of Suzanne R. Kesten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne R. Kesten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne R. Kesten more than expected).

Fields of papers citing papers by Suzanne R. Kesten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne R. Kesten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne R. Kesten. The network helps show where Suzanne R. Kesten may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suzanne R. Kesten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne R. Kesten Line = papers co-authored together Suzanne R. Kesten links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor ACS Medicinal Chemistry Letters ·Douglas S. Johnson,Cory M. Stiff,Scott E. Lazerwith,Suzanne R. Kesten,Lorraine K. Fay,Mark J. Morris,David Beidler,Marya Liimatta,Sarah E. Smith,David T. Dudley,Nalini Sadagopan,Shobha Bhattachar,S. Kesten,Tyzoon Nomanbhoy,Benjamin F. Cravatt,Kay Ahn	2010	148
2	Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH) Bioorganic & Medicinal Chemistry Letters ·Douglas S. Johnson,Kay Ahn,Suzanne R. Kesten,Scott E. Lazerwith,Yuntao Song,Mark J. Morris,Lorraine K. Fay,Tracy F. Gregory,Cory M. Stiff,James B. Dunbar,Marya Liimatta,David Beidler,Sarah E. Smith,Tyzoon Nomanbhoy,Benjamin F. Cravatt	2009	59
3	The efficient synthesis of (3R,4R,5R)-3-amino-4,5-dimethyl-octanoic acid, a chiral β-amino acid with potent affinity for the α2δ protein Tetrahedron Letters ·Ji Zhang,Peter G. Blazecka,Derek A. Pflum,J. Bozelak,Derek Vrieze,Norman L. Colbry,Garrett Hoge,David C. Boyles,Brian Samas,Timothy T. Curran,Augustine T. Osuma,Paul D. Johnson,Suzanne R. Kesten,Jacob B. Schwarz,Annise Goodman,Mark S. Plummer,Anne Akin,Yun Huang,Michael Lovdahl,Andrew Thorpe	2009	8
4	Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues Bioorganic & Medicinal Chemistry Letters ·Brian E. Kornberg,Sham S. Nikam,Jon L. Wright,Suzanne R. Kesten,Leonard T. Meltzer,Linda L. Coughenour,Bridget M. Barr,Kevin A. Serpa,Julie McCormick	2004	7
5	Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines Journal of Medicinal Chemistry ·Jonathan L. Wright,Tracy F. Gregory,Suzanne R. Kesten,Peter A. Boxer,Kevin A. Serpa,Leonard T. Meltzer,Lawrence D. Wise,Stephen Espitia,Christopher S. Konkoy,Edward R. Whittemore,Richard M. Woodward	2000	95
6	Synthesis of N-Substituted 4-(4-Hydroxyphenyl)piperidines, 4-(4-Hydroxybenzyl)piperidines, and (±)-3-(4-Hydroxyphenyl)pyrrolidines: Selective Antagonists at the 1a/2B NMDA Receptor Subtype Journal of Medicinal Chemistry ·Anthony P. Guzikowski,Amir P. Tamiz,Manuel Acosta-Burruel,Soo Hong-Bae,Sui Xiong Cai,Jon E. Hawkinson,John F. W. Keana,Suzanne R. Kesten,Christina T. Shipp,Minhtam Tran,Edward R. Whittemore,Richard M. Woodward,Jon L. Wright,Zhang‐Lin Zhou	2000	35
7	Design, Synthesis, and Evaluation of Chromen-2-ones as Potent and Selective Human Dopamine D4 Antagonists Journal of Medicinal Chemistry ·Suzanne R. Kesten,Thomas G. Heffner,Stephen J. Johnson,Thomas A. Pugsley,Jonathan L. Wright,Lawrence D. Wise	1999	99
8	Isoindolinone enantiomers having affinity for the dopamine D4 receptor Bioorganic & Medicinal Chemistry Letters ·Thomas R. Belliotti,Wouter A. Brink,Suzanne R. Kesten,John R. Rubin,David J. Wustrow,Kim Zoski,Steven Z. Whetzel,Ann E. Corbin,Thomas A. Pugsley,Thomas G. Heffner,Lawrence D. Wise	1998	194
9	Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors Journal of Medicinal Chemistry ·David J. Wustrow,Thomas R. Belliotti,Shelly A. Glase,Suzanne R. Kesten,Don E. Johnson,Norman L. Colbry,R. J. Rubin,A. C. Blackburn,Hyacinth C. Akunne,Ann E. Corbin,M. Duff Davis,Lynn M. Georgic,Steven Z. Whetzel,Kim Zoski,Thomas G. Heffner,Thomas A. Pugsley,Lawrence D. Wise	1998	25
10	Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands Bioorganic & Medicinal Chemistry Letters ·Thomas R. Belliotti,Suzanne R. Kesten,John R. Rubin,David J. Wustrow,Lynn M. Georgic,Kim Zoski,Hyacinth C. Akunne,Lawrence D. Wise	1997	15
11	Novel small molecule neurotensin antagonists: 3-(1,5-diaryl-1,5-dioxopentan-3-yl)benzoic acids Bioorganic & Medicinal Chemistry Letters ·S. J. JOHNSON,Hyacinth C. Akunne,Thomas G. Heffner,Suzanne R. Kesten,Thomas A. Pugsley,Lawrence D. Wise,David J. Wustrow	1997	3
12	4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonists Bioorganic & Medicinal Chemistry Letters ·Shelly A. Glase,Hyacinth C. Akunne,Thomas G. Heffner,Stephen J. Johnson,Suzanne R. Kesten,Robert G. MacKenzie,Peter J. Manley,Thomas A. Pugsley,Jon L. Wright,Lawrence D. Wise	1996	13
13	The Discovery and Structure-Activity Relationships of 1,2,3,6-Tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine Autoreceptor Agonists and Potential Antipsychotic Agents Journal of Medicinal Chemistry ·Jon L. Wright,Bradley W. Caprathe,Dennis M. Downing,Shelly A. Glase,Thomas G. Heffner,Juan C. Jaén,Stephen J. Johnson,Suzanne R. Kesten,Robert G. MacKenzie	1994	18
14	2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents Journal of Medicinal Chemistry ·David B. Capps,James B. Dunbar,Suzanne R. Kesten,Joan L. Shillis,Leslie M. Werbel,Jacqueline Plowman,Donald L. Ward	1992	42
15	Synthesis of the chiral 4-substituted 1-phenylcyclohexene PD137789 via intramolecular Wittig reaction The Journal of Organic Chemistry ·Stephen J. Johnson,Suzanne R. Kesten,Lawrence D. Wise	1992	6
16	Cholinergic agents: 2-oxazolidinone analogues of the acetylcholine-receptor muscarinic agonist pilocarpine Bioorganic & Medicinal Chemistry Letters ·S. H. HOBBS,Stephen J. Johnson,Suzanne R. Kesten,Michael R. Pavia,Robert E. Davis,Roy D. Schwarz,Linda L. Coughenour,Sharie L. Myers,David T. Dudley,Walter H. Moss	1991	4

About Suzanne R. Kesten

Suzanne R. Kesten is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Toxicology, having authored 16 papers that have together received 771 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers), Synthesis of heterocyclic compounds (2 papers), Cannabis and Cannabinoid Research (2 papers), Ion channel regulation and function (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Toxicology (63 citations), Organic Chemistry (468 citations) and Pharmacology (198 citations). Suzanne R. Kesten has collaborated with scholars based in United States. Frequent co-authors include Lawrence D. Wise, Thomas G. Heffner, Thomas A. Pugsley, Jonathan L. Wright, Stephen J. Johnson, Kim Zoski, Thomas R. Belliotti, David J. Wustrow, John R. Rubin and Ann E. Corbin. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact